These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38086455)

  • 21. Promise and Potential Peril With Lumacaftor for the Trafficking Defective Type 2 Long-QT Syndrome-Causative Variants, p.G604S, p.N633S, and p.R685P, Using Patient-Specific Re-Engineered Cardiomyocytes.
    O'Hare BJ; John Kim CS; Hamrick SK; Ye D; Tester DJ; Ackerman MJ
    Circ Genom Precis Med; 2020 Oct; 13(5):466-475. PubMed ID: 32940533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneous Phenotype of Long QT Syndrome Caused by the KCNH2-H562R Mutation: Importance of Familial Genetic Testing.
    Muñoz-Esparza C; García-Molina E; Salar-Alcaraz M; Peñafiel-Verdú P; Sánchez-Muñoz JJ; Martínez Sánchez J; Cabañas-Perianes V; Valdés Chávarri M; García Alberola A; Gimeno-Blanes JR
    Rev Esp Cardiol (Engl Ed); 2015 Oct; 68(10):861-8. PubMed ID: 25819988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Probucol aggravates long QT syndrome associated with a novel missense mutation M124T in the N-terminus of HERG.
    Hayashi K; Shimizu M; Ino H; Yamaguchi M; Terai H; Hoshi N; Higashida H; Terashima N; Uno Y; Kanaya H; Mabuchi H
    Clin Sci (Lond); 2004 Aug; 107(2):175-82. PubMed ID: 15043509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Mutation P.T613a in the Pore Helix of the Kv 11.1 Potassium Channel is Associated with Long QT Syndrome.
    Poulsen KL; Hotait M; Calloe K; Klaerke DA; Rebeiz A; Nemer G; Tejada MA; Refaat MM
    Pacing Clin Electrophysiol; 2015 Nov; 38(11):1304-9. PubMed ID: 26173150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overlapping LQT1 and LQT2 phenotype in a patient with long QT syndrome associated with loss-of-function variations in KCNQ1 and KCNH2.
    Cordeiro JM; Perez GJ; Schmitt N; Pfeiffer R; Nesterenko VV; Burashnikov E; Veltmann C; Borggrefe M; Wolpert C; Schimpf R; Antzelevitch C
    Can J Physiol Pharmacol; 2010 Dec; 88(12):1181-90. PubMed ID: 21164565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of fever-induced QT prolongation and torsades de pointes in patients with KCNH2 mutation.
    Usuda K; Hayashi K; Nakajima T; Kurata Y; Cui S; Kusayama T; Tsuda T; Tada H; Kato T; Sakata K; Usui S; Fujino N; Tanaka Y; Kaneko Y; Kurabayashi M; Tange S; Saito T; Ohta K; Yamagishi M; Takamura M
    Europace; 2023 Jun; 25(6):. PubMed ID: 37386841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of a novel pathogenic variant in KCNH2 associated with long QT syndrome 2 using whole exome sequencing.
    Kohansal E; Naderi N; Fazelifar AF; Maleki M; Kalayinia S
    BMC Med Genomics; 2024 May; 17(1):126. PubMed ID: 38715010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-throughput discovery of trafficking-deficient variants in the cardiac potassium channel K
    Kozek KA; Glazer AM; Ng CA; Blackwell D; Egly CL; Vanags LR; Blair M; Mitchell D; Matreyek KA; Fowler DM; Knollmann BC; Vandenberg JI; Roden DM; Kroncke BM
    Heart Rhythm; 2020 Dec; 17(12):2180-2189. PubMed ID: 32522694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utilization of the genome aggregation database, in silico tools, and heterologous expression patch-clamp studies to identify and demote previously published type 2 long QT syndrome: Causative variants from pathogenic to likely benign.
    Mattivi CL; Ye D; Tester DJ; Clemens DJ; Zhou W; Giudicessi JR; Ackerman MJ
    Heart Rhythm; 2020 Feb; 17(2):315-323. PubMed ID: 31493592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification novel LQT syndrome-associated variants in Polish population and genotype-phenotype correlations in eight families.
    Szperl M; Kozicka U; Kosiec A; Kukla P; Roszczynko M; Biernacka EK
    J Appl Genet; 2018 Nov; 59(4):463-469. PubMed ID: 30244407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism.
    Anderson CL; Delisle BP; Anson BD; Kilby JA; Will ML; Tester DJ; Gong Q; Zhou Z; Ackerman MJ; January CT
    Circulation; 2006 Jan; 113(3):365-73. PubMed ID: 16432067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rescue of protein expression defects may not be enough to abolish the pro-arrhythmic phenotype of long QT type 2 mutations.
    Perry MD; Ng CA; Phan K; David E; Steer K; Hunter MJ; Mann SA; Imtiaz M; Hill AP; Ke Y; Vandenberg JI
    J Physiol; 2016 Jul; 594(14):4031-49. PubMed ID: 26958806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of a KCNH2 variant in genotyped long QT syndrome: Romano-Ward syndrome under double mutations and acquired long QT syndrome under heterozygote.
    Fujii Y; Matsumoto Y; Hayashi K; Ding WG; Tomita Y; Fukumoto D; Wada Y; Ichikawa M; Sonoda K; Ozawa J; Makiyama T; Ohno S; Yamagishi M; Matsuura H; Horie M; Itoh H
    J Cardiol; 2017 Jul; 70(1):74-79. PubMed ID: 27816319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trafficking defect and proteasomal degradation contribute to the phenotype of a novel KCNH2 long QT syndrome mutation.
    Mihic A; Chauhan VS; Gao X; Oudit GY; Tsushima RG
    PLoS One; 2011 Mar; 6(3):e18273. PubMed ID: 21483829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KCNQ1 and KCNH2 mutations associated with long QT syndrome in a Chinese population.
    Liu W; Yang J; Hu D; Kang C; Li C; Zhang S; Li P; Chen Z; Qin X; Ying K; Li Y; Li Y; Li Z; Cheng X; Li L; Qi Y; Chen S; Wang Q
    Hum Mutat; 2002 Dec; 20(6):475-6. PubMed ID: 12442276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of novel KCNH2 mutations in type 2 long QT syndrome manifesting as seizures.
    Keller DI; Grenier J; Christé G; Dubouloz F; Osswald S; Brink M; Ficker E; Chahine M
    Can J Cardiol; 2009 Aug; 25(8):455-62. PubMed ID: 19668779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trafficking-deficient long QT syndrome mutation KCNQ1-T587M confers severe clinical phenotype by impairment of KCNH2 membrane localization: evidence for clinically significant IKr-IKs alpha-subunit interaction.
    Biliczki P; Girmatsion Z; Brandes RP; Harenkamp S; Pitard B; Charpentier F; Hébert TE; Hohnloser SH; Baró I; Nattel S; Ehrlich JR
    Heart Rhythm; 2009 Dec; 6(12):1792-801. PubMed ID: 19959132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Common variants in the hERG (KCNH2) voltage-gated potassium channel are associated with altered fasting and glucose-stimulated plasma incretin and glucagon responses.
    Engelbrechtsen L; Mahendran Y; Jonsson A; Gjesing AP; Weeke PE; Jørgensen ME; Færch K; Witte DR; Holst JJ; Jørgensen T; Grarup N; Pedersen O; Vestergaard H; Torekov S; Kanters JK; Hansen T
    BMC Genet; 2018 Mar; 19(1):15. PubMed ID: 29548277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HERG-F463L potassium channels linked to long QT syndrome reduce I(Kr) current by a trafficking-deficient mechanism.
    Yang HT; Sun CF; Cui CC; Xue XL; Zhang AF; Li HB; Wang DQ; Shu J
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):822-7. PubMed ID: 19215240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of a novel missense mutation E637K in the pore-S6 loop of HERG in a patient with long QT syndrome.
    Hayashi K; Shimizu M; Ino H; Yamaguchi M; Mabuchi H; Hoshi N; Higashida H
    Cardiovasc Res; 2002 Apr; 54(1):67-76. PubMed ID: 12062363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.